Don't forget arterial thrombosis in patients with COVID-19: A case series

Daniel D Gold1, Ramzi Kurd2, Sharon Einav3

  • 1Emergency Department, Shaare Zedek Medical Center and Hebrew University, Faculty of Medicine, Jerusalem, Israel.

Thrombosis Update
|April 15, 2024
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, or COVID-19, can cause arterial thromboembolic events, leading to severe organ damage. These arterial events occur despite heparin treatment and are often fatal, necessitating further research into prevention.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19).
  • COVID-19 is associated with a hypercoagulable state, with venous thromboembolic events frequently reported.
  • Arterial thromboembolic events in COVID-19 have not been well-described.
Abstract